Literature DB >> 4947365

DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

N P Plotnikoff, A J Kastin, M S Anderson, A V Schally.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4947365     DOI： 10.1016/0024-3205(71)90326-2

Source DB:  PubMed          Journal:  Life Sci I        ISSN： 0300-9653


× No keyword cloud information.
  13 in total

1.  On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.

Authors:  S Björkman; H Sievertsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

Review 2.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

3.  Neuroleptic-induced akathisia: a role for MSH peptides.

Authors:  R Sandyk
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.

Authors:  T Caraceni; E A Parati; F Girotti; I Celano; C Frigerio; D Cocchi; E E Müller
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

5.  Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

Authors:  A Barbeau; M Roy; A J Kastin
Journal:  Can Med Assoc J       Date:  1976-01-24       Impact factor: 8.262

6.  Proceedings: The effect of psychotropic drugs on the dopa potentiation test in mice.

Authors:  H Berendsen; B E Leonard; H Rigter
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

7.  Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.

Authors:  A J Kastin; A Barbeau
Journal:  Can Med Assoc J       Date:  1972-12-09       Impact factor: 8.262

8.  Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.

Authors:  A R Green; P H Kelly
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

9.  Theoretical studies on pro-leu-gly-nh2 conformation.

Authors:  S Kang; R Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

10.  Plasma beta-lipotropin levels in Parkinson's disease.

Authors:  M Wiesen; M D Yahr; D T Krieger
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.